{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:09:18Z","timestamp":1773860958045,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"19","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bristol Myers Squibb"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.2217\/fon-2021-0047","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T09:27:23Z","timestamp":1616750843000},"page":"2439-2448","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Treatment Patterns and Outcomes of Patients with Advanced Malignant Pleural Mesothelioma in a Community Practice Setting"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-9939","authenticated-orcid":false,"given":"David M","family":"Waterhouse","sequence":"first","affiliation":[{"name":"Oncology Hematology Care, Cincinnati, OH45242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmond D","family":"Nwokeji","sequence":"additional","affiliation":[{"name":"McKesson Life Sciences, The Woodlands, TX77380, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marley","family":"Boyd","sequence":"additional","affiliation":[{"name":"McKesson Life Sciences, The Woodlands, TX77380, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Penrod","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, NJ08540, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L","family":"Espirito","sequence":"additional","affiliation":[{"name":"McKesson Life Sciences, The Woodlands, TX77380, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J","family":"Robert","sequence":"additional","affiliation":[{"name":"McKesson Life Sciences, The Woodlands, TX77380, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda J","family":"Daumont","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Braine-l'Alleud, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145039"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016"},{"issue":"6","key":"e_1_3_4_5_1","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk N","year":"2013","unstructured":"van Zandwijk N , ClarkeC, HendersonDet al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J. Thorac. Dis.5(6), E254\u2013307 (2013).","journal-title":"J. Thorac. Dis."},{"key":"e_1_3_4_6_1","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: malignant pleural mesothelioma v2.2021 . Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for malignant pleural mesothelioma V.2.2021\u00a9. NCCN makes no warranties of any kind whatsoever regarding their content use or application and disclaims any responsibility for their application or use in any way. (2021). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31826915f1"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.982.11.3"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693406"},{"key":"e_1_3_4_10_1","unstructured":"Bristol Myers Squibb Company . OPDIVO\u00ae (nivolumab injection for intravenous use) prescribing information. NJ USA (2021). https:\/\/packageinserts.bms.com\/pi\/pi_opdivo.pdf"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1703945"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0103"},{"key":"e_1_3_4_13_1","unstructured":"Mckesson . The US Oncology Network. (2020). https:\/\/www.usoncology.com\/"},{"key":"e_1_3_4_14_1","unstructured":"Mckesson . Onmark Group purchasing organization (GPO) services. (2020). https:\/\/www.mckesson.com\/Specialty\/Group-Purchasing\/."},{"key":"e_1_3_4_15_1","unstructured":"Mckesson . Practice management - oncology. (2020). https:\/\/www.mckesson.com\/Specialty\/Practice-Management\/."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30169-9"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30420-X"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30765-4"},{"key":"e_1_3_4_19_1","unstructured":"Eli Lilly and Company . ALTIMA\u00ae (pemetrexed for injection) prescribing information. (2020). https:\/\/packageinserts.bms.com\/pi\/pi_yervoy.pdf"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm501"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0087"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.9887"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.08.011"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.007"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.04.001"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.03.006"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi187"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2577::AID-CNCR13>3.0.CO;2-S"},{"key":"e_1_3_4_32_1","unstructured":"NCCN flash updates: NCCN Guidelines\u00ae & NCCN templates\u00ae updated. (2020). https:\/\/www.nccn.org\/about\/news\/ebulletin\/ebulletindetail.aspx?ebulletinid=1142"},{"key":"e_1_3_4_33_1","unstructured":"National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: malignant pleural mesothelioma v2.2017. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.009"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T18:47:47Z","timestamp":1726598867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":32,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.2217\/fon-2021-0047"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0047","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}